============================================================
📊 BIOCON FDA PROJECT - MODEL TRAINING REPORT
Generated: 2025-07-01 01:40:30
============================================================

📊 Data Overview:
   Training Samples: 2,072
   Test Samples: 518
   Features Used: ['Close', 'Volume']
   Date Range: 2015-01-01 to 2025-06-30
   Target: 5-Day Forward Return

🧠 Model Performance:
   RandomForest:
     Train R²: 0.4581
     Test R²: -0.1098
     Train Adjusted R²: 0.4576
     Test Adjusted R²: -0.1141
     Train MSE: 0.001094
     Test MSE: 0.002693
     CV R² Mean: -0.9853 (±0.8480)

   XGBoost:
     Train R²: 0.4017
     Test R²: -0.1129
     Train Adjusted R²: 0.4011
     Test Adjusted R²: -0.1172
     Train MSE: 0.001208
     Test MSE: 0.002701
     CV R² Mean: -0.7547 (±0.6253)

   LinearRegression:
     Train R²: 0.0151
     Test R²: 0.0103
     Train Adjusted R²: 0.0142
     Test Adjusted R²: 0.0065
     Train MSE: 0.001989
     Test MSE: 0.002402
     CV R² Mean: -0.3325 (±0.6413)

📈 Analysis:
   Best Model: LinearRegression (Test Adjusted R²: 0.0065)
   Adjusted R² accounts for the number of features, providing a robust measure of model fit.
   Lower MSE indicates better prediction accuracy.
   Models use available stock and sentiment data.

🎯 Top Features (Random Forest):
     Close: 0.6089
     Volume: 0.3911

📁 Outputs:
   ✅ predictions.csv
   ✅ feature_importance.csv
   ✅ performance_report.txt
   ✅ charts/model_performance.png
   ✅ charts/predictions_vs_actual.png
   ✅ charts/feature_importance.png
   ✅ charts/stock_price.png
============================================================